These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6343980)

  • 1. Colonial variation in Serratia marcescens together with antibiotic resistance.
    Ruhen RW; Wetherall FM
    Pathology; 1983 Jan; 15(1):65-6. PubMed ID: 6343980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific aminoglycoside cross-resistance of Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):204-13. PubMed ID: 378576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genes of resistance to aminoglycoside antibiotics in clinical strains of Serratia marcescens and the enzyme encoded by them].
    Kolganov AN; Vakulenko SB
    Antibiot Khimioter; 1992 Nov; 37(11):10-4. PubMed ID: 1300924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of eight aminoglycosides against isolates of Serratia marcescens from four hospitals.
    Verbist L; Vandepitte J; Vandeven J
    J Antimicrob Chemother; 1978 Jan; 4(1):47-55. PubMed ID: 342482
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ABC-Type Efflux Pump MacAB Is Involved in Protection of Serratia marcescens against Aminoglycoside Antibiotics, Polymyxins, and Oxidative Stress.
    Shirshikova TV; Sierra-Bakhshi CG; Kamaletdinova LK; Matrosova LE; Khabipova NN; Evtugyn VG; Khilyas IV; Danilova IV; Mardanova AM; Sharipova MR; Bogomolnaya LM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692192
    [No Abstract]   [Full Text] [Related]  

  • 7. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
    Langstaff D; Schueler S; Righter J
    J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug resistance of bacteria--the current status and future prospect. 4. Serratia].
    Kimura S
    Nihon Rinsho; 1984 Mar; 42(3):671-5. PubMed ID: 6381804
    [No Abstract]   [Full Text] [Related]  

  • 10. Some properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with non-enzyme-dependent multiple resistance to beta-lactam antibiotics, aminoglycosides, and quinolones.
    Dang P; Gutmann L; Quentin C; Williamson R; Collatz E
    Rev Infect Dis; 1988; 10(4):899-904. PubMed ID: 3055181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
    Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
    Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C
    Epidemiol Infect; 1994 Feb; 112(1):125-31. PubMed ID: 8119351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin-resistant Serratia marcescens endophthalmitis.
    Gammon JA; Schwab I; Joseph P
    Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effects of gentamicin and netilmicin on Serratia marcescens: effects on hydrophobicity and motility.
    Majtánová L; Majtán V
    Folia Microbiol (Praha); 2000; 45(1):45-9. PubMed ID: 11200671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New R-plasmids in strains of Serratia marcescens with multiple drug resistance].
    Kurnosova LM; Domaradskiĭ IV; Morshchakova GN; Kruglova AA; Smolianskaia AZ
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):3-6. PubMed ID: 3521159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serratia marcescens: biochemical characteristics, antimicrobial sensitivity and clinical significance.
    Puthucheary SD; Ngeow YF
    Malays J Pathol; 1981 Aug; 4():35-41. PubMed ID: 6764658
    [No Abstract]   [Full Text] [Related]  

  • 18. Outer membrane protein alterations in Serratia marcescens resistant against aminoglycoside and beta-lactam antibiotics.
    Traub WH; Bauer D
    Chemotherapy; 1987; 33(3):172-6. PubMed ID: 3297527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1983; 29(4):265-74. PubMed ID: 6307604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. II. Aminoglycosides: amikacin, gentamicin, and netilmicin.
    Traub WH
    Chemotherapy; 1982; 28(6):434-43. PubMed ID: 6761079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.